Currently Open for Comment

Regulatory documents with comment periods that haven't closed yet. These are opportunities for public participation. ⚠ comment_end_date holds the FULL UTC INSTANT of the close, not a calendar date, despite its name: '2026-08-29T03:59:59Z' is 11:59:59 PM EASTERN on 2026-08-28. Convert to America/New_York before reading it as a deadline — the UTC calendar date is one day LATER than the official ET deadline for every end-of-day close. (queue #644)

Custom SQL query returning 100 rows (hide) 

SELECT /* DD-COUPLE:q498.deadline-grain.v1 */ d.id, d.agency_id, d.title, d.document_type, d.posted_date, d.comment_start_date, d.comment_end_date, d.docket_id, CAST(julianday(d.comment_end_date) - julianday('now') AS INTEGER) AS days_remaining, (SELECT COUNT(*) FROM comments c WHERE c.docket_id = d.docket_id) AS comments_so_far FROM documents d WHERE d.comment_end_date IS NOT NULL AND julianday(d.comment_end_date) > julianday('now') AND d.withdrawn = 0 ORDER BY d.comment_end_date ASC LIMIT 100

Edit SQL

This data as json, CSV

idagency_idtitledocument_typeposted_datecomment_start_datecomment_end_datedocket_iddays_remainingcomments_so_far
EPA-HQ-OPPT-2018-0446-0083 EPA o-Dichlorobenzene and p-Dichlorobenzene; Draft Risk Evaluations Under the Toxic Substances Control Act (TSCA); Notice of Availability and Request for Comment Notice 2026-08-10T04:00:00Z 2026-08-10T04:00:00Z 2026-10-10T03:59:59Z EPA-HQ-OPPT-2018-0446 1 35
EPA-HQ-OPPT-2018-0444-0074 EPA o-Dichlorobenzene and p-Dichlorobenzene; Draft Risk Evaluations Under the Toxic Substances Control Act (TSCA); Notice of Availability and Request for Comment Notice 2026-08-10T04:00:00Z 2026-08-10T04:00:00Z 2026-10-10T03:59:59Z EPA-HQ-OPPT-2018-0444 1 34
EPA-HQ-OFA-2026-2542-0001 EPA Agency Information Collection Activities; Proposals, Submissions, and Approvals: General Performance Reporting for Assistance Programs, Promoting Readiness and Enhancing Proficiency to Advance Reporting and Data, and National Estuary Program Notice 2026-09-09T04:00:00Z 2026-09-09T04:00:00Z 2026-10-10T03:59:59Z EPA-HQ-OFA-2026-2542 1 0
EPA-R08-OAR-2023-0495-0065 EPA Air Quality State Implementation Plans; Approvals and Promulgations: North Dakota; Reconsideration and Repeal of Air Plan Partial Approval and Partial Disapproval of Regional Haze State Implementation Plan for the Second Implementation Period Proposed Rule 2026-09-09T04:00:00Z 2026-09-09T04:00:00Z 2026-10-10T03:59:59Z EPA-R08-OAR-2023-0495 1 31
EPA-HQ-OW-2025-0322-15447 EPA Updated Definition of “Waters of the United States” Proposed Rule 2026-09-09T04:00:00Z 2026-09-09T04:00:00Z 2026-10-10T03:59:59Z EPA-HQ-OW-2025-0322 1 15338
FDA-2025-E-5206-0005 FDA Determination of Regulatory Review Period for Purposes of Patent Extension; BRINSUPRI Notice 2026-08-10T04:00:00Z 2026-08-10T04:00:00Z 2026-10-10T03:59:59Z FDA-2025-E-5206 1 0
FDA-2026-N-7630-0001 FDA Radiology Devices; Reclassification of Digital Breast Tomosynthesis System Proposed Rule 2026-08-10T04:00:00Z 2026-08-10T04:00:00Z 2026-10-10T03:59:59Z FDA-2026-N-7630 1 1
FDA-2025-E-0707-0005 FDA Determination of Regulatory Review Period for Purposes of Patent Extension; DAYVIGO Notice 2026-08-10T04:00:00Z 2026-08-10T04:00:00Z 2026-10-10T03:59:59Z FDA-2025-E-0707 1 0
FDA-2026-N-9737-0001 FDA Notice of Data Availability and Announcement of Open Public Comment Period: Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants - Nifedipine Other 2026-09-11T04:00:00Z 2026-09-11T04:00:00Z 2026-10-13T03:59:59Z FDA-2026-N-9737 4 0
APHIS-2026-0265-0001 APHIS Petition for a Determination of Nonregulated Status and Draft Plant Pest Risk Assessment: Early and Near-Continuous Blooming European Plum (Prunus domestica) Lines (34 plum and 157 plum) Notice 2026-08-14T04:00:00Z 2026-08-14T04:00:00Z 2026-10-14T03:59:59Z APHIS-2026-0265 5 3
EPA-HQ-OLEM-2026-4159-0001 EPA Hazardous and Solid Waste Management System: Disposal of Coal Combustion Residuals from Electric Utilities; Federal CCR Permit Program; General Permit Provisions Proposed Rule 2026-07-14T04:00:00Z 2026-07-14T04:00:00Z 2026-10-14T03:59:59Z EPA-HQ-OLEM-2026-4159 5 1
EPA-HQ-OPPT-2025-2433-0001 EPA 2026 Unified Agenda of Regulatory and Deregulatory Actions Notice 2026-08-14T04:00:00Z 2026-08-14T04:00:00Z 2026-10-14T03:59:59Z EPA-HQ-OPPT-2025-2433 5 1
EPA-HQ-OLEM-2025-3225-0001 EPA 2026 Unified Agenda of Regulatory and Deregulatory Actions Notice 2026-08-14T04:00:00Z 2026-08-14T04:00:00Z 2026-10-14T03:59:59Z EPA-HQ-OLEM-2025-3225 5 1
EPA-HQ-OAR-2025-3160-0001 EPA 2026 Unified Agenda of Regulatory and Deregulatory Actions Notice 2026-08-14T04:00:00Z 2026-08-14T04:00:00Z 2026-10-14T03:59:59Z EPA-HQ-OAR-2025-3160 5 1
EPA-HQ-OPPT-2015-0436-0048 EPA Agency Information Collection Activities; Proposals, Submissions, and Approvals: Generic Clearance for TSCA Section 4 Test Rules, Test Orders, Enforceable Consent Agreements, Voluntary Data Submissions, and Exemptions from Testing Requirement (Renewal) Notice 2026-08-11T04:00:00Z 2026-08-11T04:00:00Z 2026-10-14T03:59:59Z EPA-HQ-OPPT-2015-0436 5 11
FDA-2026-D-7957-0002 FDA Container Closure Systems for Human Drugs and Biological Products; Guidance for Industry - Draft Guidance Other 2026-08-14T04:00:00Z 2026-08-14T04:00:00Z 2026-10-14T03:59:59Z FDA-2026-D-7957 5 6
FDA-2016-N-3120-0570 FDA Kremers Urban Pharmaceuticals, Inc.; Grant of Hearing Request Regarding a Proposal To Withdraw Approval of an Abbreviated New Drug Application for Extended-Release Methylphenidate Tablets Notice 2026-08-13T04:00:00Z 2026-08-13T04:00:00Z 2026-10-14T03:59:59Z FDA-2016-N-3120 5 4
FDA-2026-N-2917-0002 FDA Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Generic Clearance for Qualitative Data To Support Social and Behavioral Research for Food, Dietary Supplements, Cosmetics, and Animal Food and Feed Notice 2026-09-11T04:00:00Z 2026-09-11T04:00:00Z 2026-10-14T03:59:59Z FDA-2026-N-2917 5 0
FWS-HQ-MB-2026-2146-0001 FWS Agency Information Collection Activities; Federal Fish and Wildlife Permit Applications and Reports-Migratory Birds Notice 2026-08-13T04:00:00Z 2026-08-13T04:00:00Z 2026-10-14T03:59:59Z FWS-HQ-MB-2026-2146 5 0
FWS-R8-ES-2026-2971-0001 FWS Receipt of Incidental Take Permit Application and Proposed Habitat Conservation Plan for Woodward 46 Specific Plan Project, City of San Marcos, CA; Categorical Exclusion Notice 2026-09-11T04:00:00Z 2026-09-11T04:00:00Z 2026-10-14T03:59:59Z FWS-R8-ES-2026-2971 5 0
USDA_FRDOC_0001-3365 USDA Request for Information: Modernization of Regulations Proposed Rule 2026-09-11T04:00:00Z 2026-09-11T04:00:00Z 2026-10-14T03:59:59Z USDA_FRDOC_0001 5 2
EPA-R09-OAR-2026-4885-0001 EPA Clean Data Determination; 1997 8-hour Ozone Standards; California; Sacramento Metro Area Proposed Rule 2026-09-14T04:00:00Z 2026-09-14T04:00:00Z 2026-10-15T03:59:59Z EPA-R09-OAR-2026-4885 6 0
EPA-R03-OAR-2026-4522-0001 EPA State Plans for Designated Facilities and Pollutants; Approvals and Promulgations: District of Columbia; Negative Declaration for Existing Other Solid Waste Incinerators Proposed Rule 2026-09-14T04:00:00Z 2026-09-14T04:00:00Z 2026-10-15T03:59:59Z EPA-R03-OAR-2026-4522 6 0
EPA-R03-OAR-2026-4225-0001 EPA State Plans for Designated Facilities and Pollutants; Approvals and Promulgations: Maryland; Negative Declaration for Existing Other Solid Waste Incinerators Proposed Rule 2026-09-14T04:00:00Z 2026-09-14T04:00:00Z 2026-10-15T03:59:59Z EPA-R03-OAR-2026-4225 6 0
FDA-2026-N-2740-0003 FDA Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Customer/Partner Customer Service Satisfaction Surveys Notice 2026-09-14T04:00:00Z 2026-09-14T04:00:00Z 2026-10-15T03:59:59Z FDA-2026-N-2740 6 1
EPA-R09-OAR-2021-0864-0006 EPA Draft Permit for Cache Creek Casino Resort Other 2026-09-15T04:00:00Z 2026-09-15T04:00:00Z 2026-10-16T03:59:59Z EPA-R09-OAR-2021-0864 7 0
FWS-HQ-IA-2026-3070-0001 FWS Foreign Endangered Species; Receipt of Permit Applications Notice 2026-09-15T04:00:00Z 2026-09-15T04:00:00Z 2026-10-16T03:59:59Z FWS-HQ-IA-2026-3070 7 0
EPA-HQ-OPP-2022-0743-0004 EPA Pesticide Tolerance; Exemptions, Petitions, Revocations, etc.: Calcium Carbonate Rule 2026-08-17T04:00:00Z 2026-08-17T04:00:00Z 2026-10-17T03:59:59Z EPA-HQ-OPP-2022-0743 8 3
FDA-2026-N-8328-0001 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; Imports and Electronic Import Entries Notice 2026-08-17T04:00:00Z 2026-08-17T04:00:00Z 2026-10-17T03:59:59Z FDA-2026-N-8328 8 0
FDA-2025-E-0486-0005 FDA Determination of Regulatory Review Period for Purposes of Patent Extension; BIZENGRI Notice 2026-08-17T04:00:00Z 2026-08-17T04:00:00Z 2026-10-17T03:59:59Z FDA-2025-E-0486 8 0
FDA-2025-E-0488-0005 FDA Determination of Regulatory Review Period for Purposes of Patent Extension; BIZENGRI Notice 2026-08-17T04:00:00Z 2026-08-17T04:00:00Z 2026-10-17T03:59:59Z FDA-2025-E-0488 8 0
FDA-2026-N-7757-0001 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; Third Party Disclosure and Recordkeeping Requirements for Reportable Food Notice 2026-08-17T04:00:00Z 2026-08-17T04:00:00Z 2026-10-17T03:59:59Z FDA-2026-N-7757 8 0
FDA-2026-N-8249-0001 FDA Gastroenterology-Urology Devices; Reclassification of Diagnostic Endoscopic Light Source Systems To Be Renamed Cystoscopic Systems Intended as an Aid for Detection of Bladder Cancer Proposed Rule 2026-08-17T04:00:00Z 2026-08-17T04:00:00Z 2026-10-17T03:59:59Z FDA-2026-N-8249 8 1
FDA-2025-E-0490-0005 FDA Determination of Regulatory Review Period for Purposes of Patent Extension; BIZENGRI Notice 2026-08-17T04:00:00Z 2026-08-17T04:00:00Z 2026-10-17T03:59:59Z FDA-2025-E-0490 8 0
FDA-2025-N-6224-0011 FDA Medical Devices; Classification of Accessories Distinct From Other Devices; Proposed List of Accessories Suitable for Class I; Request for Comments Proposed Rule 2026-08-17T04:00:00Z 2026-08-17T04:00:00Z 2026-10-17T03:59:59Z FDA-2025-N-6224 8 8
FDA-2025-E-0485-0005 FDA Determination of Regulatory Review Period for Purposes of Patent Extension; BIZENGRI Notice 2026-08-17T04:00:00Z 2026-08-17T04:00:00Z 2026-10-17T03:59:59Z FDA-2025-E-0485 8 0
FDA-2025-E-0489-0005 FDA Determination of Regulatory Review Period for Purposes of Patent Extension; BIZENGRI Notice 2026-08-17T04:00:00Z 2026-08-17T04:00:00Z 2026-10-17T03:59:59Z FDA-2025-E-0489 8 0
FDA-2026-N-8163-0001 FDA Reauthorization of the Prescription Drug User Fee Act; Public Meeting; Request for Comments Notice 2026-08-14T04:00:00Z 2026-08-14T04:00:00Z 2026-10-17T03:59:59Z FDA-2026-N-8163 8 3
FDA-2025-N-0873-0014 FDA Reauthorization of the Generic Drug User Fee Amendments; Public Meeting; Request for Comments Notice 2026-08-11T04:00:00Z 2026-08-11T04:00:00Z 2026-10-18T03:59:59Z FDA-2025-N-0873 9 14
APHIS-2026-1090-0001 APHIS Petition: Pioneer Hi-Bred International, Inc.; Determination of Nonregulated Status and Draft Plant Pest Risk Assessment for Insect Resistant COR-23134-4 Soybean (Glycine max) Notice 2026-08-18T04:00:00Z 2026-08-18T04:00:00Z 2026-10-20T03:59:59Z APHIS-2026-1090 11 3
APHIS-2026-1354-0001 APHIS Agency Information Collection Activities; Proposals, Submissions, and Approvals: Animal Care; Standards for Birds Not Bred for Use in Research under the Animal Welfare Act Notice 2026-08-18T04:00:00Z 2026-08-18T04:00:00Z 2026-10-20T03:59:59Z APHIS-2026-1354 11 0
EPA-HQ-OPP-2024-0548-0003 EPA Pesticide Tolerance; Exemptions, Petitions, Revocations, etc.: Cypermethrin Rule 2026-08-20T04:00:00Z 2026-08-20T04:00:00Z 2026-10-20T03:59:59Z EPA-HQ-OPP-2024-0548 11 0
EPA-HQ-OPPT-2018-0488-0065 EPA Ethylene Dibromide Draft Risk Evaluation Under the Toxic Substances Control Act (TSCA); Notice of Availability and Request for Comment Notice 2026-08-19T04:00:00Z 2026-08-19T04:00:00Z 2026-10-20T03:59:59Z EPA-HQ-OPPT-2018-0488 11 32
EPA-HQ-OW-2026-6965-0001 EPA Updates to the National Pollutant Discharge Elimination System Definitions and Exclusions Proposed Rule 2026-09-04T04:00:00Z 2026-09-04T04:00:00Z 2026-10-20T03:59:59Z EPA-HQ-OW-2026-6965 11 16
FDA-2017-D-5974-0013 FDA Determining Whether to Submit an ANDA or a 505(b)(2) Application; Guidance for Industry; Draft Guidance Other 2026-08-18T04:00:00Z 2026-08-18T04:00:00Z 2026-10-20T03:59:59Z FDA-2017-D-5974 11 6
FDA-2017-D-5974-0012 FDA Determining Whether To Submit an ANDA or a 505(b)(2) Application; Draft Guidance for Industry; Availability Notice 2026-08-18T04:00:00Z 2026-08-18T04:00:00Z 2026-10-20T03:59:59Z FDA-2017-D-5974 11 6
FDA-2026-N-5479-0001 FDA Testosterone Use in Menopausal Women; Public Workshop; Request for Comments Notice 2026-08-18T04:00:00Z 2026-08-18T04:00:00Z 2026-10-20T03:59:59Z FDA-2026-N-5479 11 1072
FDA-2026-N-7874-0001 FDA Considerations for the Regulation of Generative AI-Enabled Medical Devices: Discussion Paper and Request for Feedback Other 2026-08-18T04:00:00Z 2026-08-18T04:00:00Z 2026-10-20T03:59:59Z FDA-2026-N-7874 11 98
EPA-HQ-OW-2014-0359-0042 EPA Agency Information Collection Activities; Proposals, Submissions, and Approvals: Information Request for the Underground Injection Control Program Notice 2026-08-21T04:00:00Z 2026-08-21T04:00:00Z 2026-10-21T03:59:59Z EPA-HQ-OW-2014-0359 12 5
EPA-HQ-OPP-2022-0455-0011 EPA Pesticide Tolerances: Carboxin Rule 2026-08-21T04:00:00Z 2026-08-21T04:00:00Z 2026-10-21T03:59:59Z EPA-HQ-OPP-2022-0455 12 2
FDA-2007-D-0369-2640 FDA Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability Notice 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2657 FDA PSG_218475 - Draft Guidance on Epinephrine Bitartrate Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2673 FDA PSG_214662 - Draft Guidance on Maralixibat Chloride Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2674 FDA PSG_217593 - Draft Guidance on Meloxicam Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2687 FDA PSG_020573 - Draft Guidance on Sodium Phenylbutyrate Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2689 FDA PSG_219839 - Draft Guidance on Sunvozertinib Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2654 FDA PSG_204370 - Draft Guidance on Cariprazine Hydrochloride Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2659 FDA PSG_022180 - Draft Guidance on Ferumoxytol Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2661 FDA PSG_020496 - Draft Guidance on Glimepiride Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2662 FDA PSG_213876 - Draft Guidance on Hydrocortisone Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2664 FDA PSG_209939 - Draft Guidance on Letermovir Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2668 FDA PSG_021924 - Draft Guidance on Levothyroxine Sodium Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2686 FDA PSG_219301 - Draft Guidance on Sebetralstat Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2642 FDA PSG_208147 - Draft Guidance on Amphetamine; Amphetamine Aspartate/Dextroamphetamine Sulfate Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2646 FDA PSG_214510 - Draft Guidance on Benzoyl Peroxide Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2663 FDA PSG_206185 - Draft Guidance on Latanoprost Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2667 FDA PSG_021731 - Draft Guidance on Leuprolide Acetate Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2671 FDA PSG_219847 - Draft Guidance on Lisdexamfetamine Dimesylate Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2679 FDA PSG_203340 - Draft Guidance on Nimodipine Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2681 FDA PSG_208558 - Draft Guidance on Olaparib Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2685 FDA PSG_219685 - Draft Guidance on Rilzabrutinib Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2641 FDA PSG_204325 - Draft Guidance on Amphetamine Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2649 FDA PSG_217729 - Draft Guidance on Bosutinib Monohydrate Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2650 FDA PSG_217673 - Draft Guidance on Brensocatib Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2652 FDA PSG_020816 - Draft Guidance on Brinzolamide Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2655 FDA PSG_050600 - Draft Guidance on Clindamycin Phosphate Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2660 FDA PSG_020243 - Draft Guidance on Fluvoxamine Maleate Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2675 FDA PSG_218395 - Draft Guidance on Meloxicam Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2676 FDA PSG_215211 - Draft Guidance on Miglustat Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2680 FDA PSG_021008 - Draft Guidance on Octreotide Acetate Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2690 FDA PSG_219713 - Draft Guidance on Taletrectinib Adipate Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2691 FDA PSG_211801 - Draft Guidance on Tenapanor Hydrochloride Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2695 FDA PSG_022328 - Draft Guidance on Zolpidem Tartrate Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2643 FDA PSG_210526 - Draft Guidance on Amphetamine;Amphetamine Aspartate/Dextroamphetamine Sulfate Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2647 FDA PSG_214902 - Draft Guidance on Benzoyl Peroxide; Tretinoin Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2656 FDA PSG_215425 - Draft Guidance on Epinephrine Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2658 FDA PSG_203565 - Draft Guidance on Ferric Carboxymaltose Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2665 FDA PSG_021343 - Draft Guidance on Leuprolide Acetate Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2669 FDA PSG_215029 - Draft Guidance on Lidocaine Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2670 FDA PSG_021977 - Draft Guidance on Lisdexamfetamine Dimesylate Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2672 FDA PSG_219485 - Draft Guidance on Maralixibat Chloride Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2677 FDA PSG_020415 - Draft Guidance on Mirtazapine Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2678 FDA PSG_215793 - Draft Guidance on Mitomycin Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2683 FDA PSG_020781 - Draft Guidance on Ondansetron Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2684 FDA PSG_211150 - Draft Guidance on Pitolisant Hydrochloride Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2688 FDA PSG_214860 - Draft Guidance on Sodium Phenylbutyrate Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2692 FDA PSG_219304 - Draft Guidance on Vimseltinib Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2693 FDA PSG_021774 - Draft Guidance on Zolpidem Tartrate Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2644 FDA PSG_219696 - Draft Guidance on Avatrombopag Maleate Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560
FDA-2007-D-0369-2645 FDA PSG_207924 - Draft Guidance on Baricitinib Other 2026-08-24T04:00:00Z 2026-08-24T04:00:00Z 2026-10-24T03:59:59Z FDA-2007-D-0369 15 560